Clinical Trial Update: Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis [Phase 2]

View source ↗

Summary

This report summarizes a Phase 2 trial evaluating the efficacy and safety of rhuMAb Beta7 in adults with moderate to severe Ulcerative Colitis, sponsored by Gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• rhuMAb Beta7

Snippet

Sponsor: Genentech, Inc. | Conditions: Ulcerative Colitis | Phase 2 | Status: COMPLETED